Literature DB >> 30551398

Piperlongumine, a piper alkaloid targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer.

Sandeep Kumar1, Navneet Agnihotri2.   

Abstract

Colorectal cancer (CRC) is the most common carcinoma of the digestive tract. The slow growing nature of CRC offers a great opportunity for prevention strategies. The concept of chemoprevention of colorectal cancer using plant derived natural products is gaining substantial attention because it is an inherently safe and cost-effective alternative to conventional cancer therapies. Piperlongumine (PL), a natural alkaloid present in Piper longum Linn has been reported to exhibit notable anticancer effects in various in vitro studies. Nonetheless, the chemopreventive potential of PL has not been studied in experimentally induced colon cancer yet. Ras/PI3K/Akt/mTOR signaling axis plays a central role in promoting tumor cell growth, proliferation and survival by inhibiting apoptosis. In the present study, we demonstrated, for the first time, the chemopreventive effects of PL in DMH + DSS induced colon carcinogenesis animal model. We showed that PL displayed potent antineoplastic activity against colon cancer cell growth by targeting Ras proteins and PI3K/Akt signaling cascade. PL mediated inhibition of tumor cell growth was associated with inhibition of Ras protein levels and its preferred companion protein PI3K levels that led to suppressed activity of Akt/NF-κB, c-Myc and cyclin D1. It was also found that PL arrested the cell cycle progression at G2/M phase and induced mitochondrial apoptotic pathway by downregulating Bcl-2 levels. Furthermore, the results of liver and kidney toxicity suggested that PL exhibit no toxicity in animals. Our results suggest that PL may be an effective chemopreventive agent for colon cancer.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cell proliferation; Colorectal cancer; PI3K/Akt/mTOR signaling pathway; Piperlongumine

Mesh:

Substances:

Year:  2018        PMID: 30551398     DOI: 10.1016/j.biopha.2018.10.182

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  12 in total

1.  Piperlongumine targets NF-κB and its downstream signaling pathways to suppress tumor growth and metastatic potential in experimental colon cancer.

Authors:  Sandeep Kumar; Navneet Agnihotri
Journal:  Mol Cell Biochem       Date:  2021-01-12       Impact factor: 3.396

2.  Small Molecule Regulators of Ferroptosis.

Authors:  Sylvain Debieu; Stéphanie Solier; Ludovic Colombeau; Antoine Versini; Fabien Sindikubwabo; Alison Forrester; Sebastian Müller; Tatiana Cañeque; Raphaël Rodriguez
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases in Colorectal Cancer Patients.

Authors:  Pavel Vodicka; Marketa Urbanova; Pavol Makovicky; Kristyna Tomasova; Michal Kroupa; Rudolf Stetina; Alena Opattova; Klara Kostovcikova; Anna Siskova; Michaela Schneiderova; Veronika Vymetalkova; Ludmila Vodickova
Journal:  Int J Mol Sci       Date:  2020-04-02       Impact factor: 5.923

Review 4.  Natural Products Attenuating Biosynthesis, Processing, and Activity of Ras Oncoproteins: State of the Art and Future Perspectives.

Authors:  Renata Tisi; Vadim Gaponenko; Marco Vanoni; Elena Sacco
Journal:  Biomolecules       Date:  2020-11-10

5.  C5aR deficiency attenuates the breast cancer development via the p38/p21 axis.

Authors:  Jian Chen; Zi-Han Sun; Li-Ying Chen; Feng Xu; Yun-Pei Zhao; Gui-Qing Li; Ming Tang; You Li; Quan-You Zheng; Shu-Feng Wang; Xin-Hua Yang; Yu-Zhang Wu; Gui-Lian Xu
Journal:  Aging (Albany NY)       Date:  2020-07-15       Impact factor: 5.682

6.  Bromamine T (BAT) Exerts Stronger Anti-Cancer Properties than Taurine (Tau).

Authors:  Stella Baliou; Maria Goulielmaki; Petros Ioannou; Christina Cheimonidi; Ioannis P Trougakos; Markus Nagl; Anthony M Kyriakopoulos; Vassilis Zoumpourlis
Journal:  Cancers (Basel)       Date:  2021-01-07       Impact factor: 6.639

7.  Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer.

Authors:  Jia-Rong Huang; Sheng-Te Wang; Meng-Ning Wei; Kun Liu; Jing-Wen Fu; Zi-Hao Xing; Zhi Shi
Journal:  Front Pharmacol       Date:  2020-11-12       Impact factor: 5.810

Review 8.  MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer Resistance.

Authors:  Crescenzo Massaro; Elham Safadeh; Giulia Sgueglia; Hendrik G Stunnenberg; Lucia Altucci; Carmela Dell'Aversana
Journal:  Cells       Date:  2020-12-30       Impact factor: 6.600

Review 9.  Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies.

Authors:  Shaila A Shetu; Debasish Bandyopadhyay
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

Review 10.  Treating Senescence like Cancer: Novel Perspectives in Senotherapy of Chronic Diseases.

Authors:  Alessia Mongelli; Sandra Atlante; Veronica Barbi; Tiziana Bachetti; Fabio Martelli; Antonella Farsetti; Carlo Gaetano
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.